Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/25/2020 05/26/2020 05/27/2020 05/28/2020 05/29/2020 Date
62.13(c) 61.37(c) 62(c) 62.96(c) 60.72(c) Last
5 271 776 3 269 187 3 979 631 3 275 258 5 283 029 Volume
+7.77% -1.22% +1.03% +1.55% -3.56% Change
More quotes
Financials
Sales 2020 44 246 M 49 144 M 49 144 M
Net income 2020 4 544 M 5 047 M 5 047 M
Net Debt 2020 29 621 M 32 899 M 32 899 M
P/E ratio 2020 13,9x
Yield 2020 4,81%
Sales 2021 45 891 M 50 971 M 50 971 M
Net income 2021 5 066 M 5 627 M 5 627 M
Net Debt 2021 26 805 M 29 772 M 29 772 M
P/E ratio 2021 12,4x
Yield 2021 5,05%
Capitalization 59 653 M 66 318 M 66 256 M
EV / Sales 2020 2,02x
EV / Sales 2021 1,88x
Nbr of Employees 102 201
Free-Float 100,0%
More Financials
Company
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ; - OTC... 
Sector
Pharmaceuticals
Calendar
06/25Capital Markets Day
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
05/29BAYER AG : Gets a Buy rating from Bernstein
MD
05/29BAYER : Efficacy of Vitrakvi™ (larotrectinib) further established with con..
PU
05/29BAYER : Elanco proposes divestments of some animal health products in Bayer acqu..
AQ
05/28TCR-2 Therapeutics Hires Key Business Development and Regulatory Affairs Cell..
AQ
05/28FCA Gives Guidance For Common PM(NOC) Trials Involving Multiple Actions
AQ
05/27German chemicals industry sees coronavirus hitting 2020 revenue
RE
05/27Rising Swiss rivalry as Roche and Novartis target same diseases
RE
05/26GLOBAL MARKETS LIVE: Labs step up efforts to find coronavirus vaccine
05/26BAYER AG : Deutsche Bank reaffirms its Buy rating
MD
05/26NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/26NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/26NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/25NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/25NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/25NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
News in other languages on BAYER AG
05/29BAYER AG : Bernstein favorable sur le dossier
05/29BAYER AG : Gets a Buy rating from Bernstein
05/29Bernstein belässt Bayer auf 'Outperform' - Ziel 88 Euro
05/29BAYER : Efficacy of Vitrakvi™ (larotrectinib) further established with con..
05/29BAYER : Elanco proposes divestments of some animal health products in Bayer acqu..
More news
Analyst Recommendations on BAYER AG
More recommendations
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 80,44 €
Last Close Price 60,72 €
Spread / Highest target 81,2%
Spread / Average Target 32,5%
Spread / Lowest Target -55,6%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Norbert Winkeljohann Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Paul Achleitner Member-Supervisory Board
Reiner Hoffmann Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-16.60%66 318
JOHNSON & JOHNSON1.97%387 206
ROCHE HOLDING AG8.68%301 088
PFIZER, INC.-2.53%212 084
MERCK & CO., INC.-11.25%199 505
NOVARTIS AG-9.27%190 322